Exploring the expression of cancer stem cell marker – Aldehyde dehydrogenase isoenzyme 1A1 (ALDH1A1) in various molecular subtypes of breast cancer

Key Points

• ALDH1A1 expression varies significantly among different molecular subtypes of breast cancer, indicating its role in cancer stem cells.
• The study highlights that ALDH1A1 may serve as a potential biomarker for identifying aggressive breast cancer characteristics.
• Assessment revealed that higher levels of ALDH1A1 correlate with certain aggressive breast cancer subtypes, possibly informing treatment decisions.
• Findings support the need for further exploration of ALDH1A1 as a therapeutic target in breast cancer management.